Mount Sinai Morningside’s Post

Asensus proudly announces the adoption of the Senhance® Surgical System by Sendai Tokushukai Hospital in Japan. This collaboration marks a significant advancement toward empowering surgeons and care teams with leading-edge technology. Asensus is dedicated to advancing minimally invasive surgery worldwide, consistently enhancing patient care through innovative technology. The Senhance System and Intelligent Surgical Unit™ (ISU™) continue to empower surgeons with nuanced, real-time data insights, enabling more informed surgical decision-making. This fosters the development of procedures that are not only safer but also more predictable, helping to ensuring superior outcomes. We are excited to see the positive impact this collaboration will have on surgical outcomes and patient recovery. https://lnkd.in/eeusfVdY #Asensus #Senhance #FutureofSurgery

Reduce patient ventilator time, and preserve critical ICU resources. Maintain chest tube patency — reduce ICU length of stay, get patients home faster. https://clearflow.com/icu/ #cardiacsurgery #cardiology #ICU #cardiovascular #thoracicsurgery #cardiothoracicsurgery #surgery

In case you missed us at The Society of Thoracic Surgeons conference last week, here are some of the highlights! As February kicks off #HeartHealth Month, Lazarus 3D is excited to launch #PreSure and #SkillSure for all cardiothoracic indications to support patient safety and outcomes in surgical care for CT/CV procedures in adults and peds. Takeaways from the #STS2024: 🎯 Pioneers and global leaders in med device have transformed care for patients with structural heart disease at an unprecedented pace. - Hot off the press, Edwards Lifesciences just received FDA approval for EVOQUE, an artificial tricuspid valve that can be implanted using a delivery catheter without open-heart surgery. - Just last month, Abbott launched Navitor, their latest transcatheter aortic valve implant system (TAVI) to treat patients with severe aortic stenosis. - Dr. Leonard Y. Lee and Dr. George Arnaoutakis showcased their experience with Epic Max, Abbott's latest aortic tissue valve addition! - We had the opportunity to perform bronchoscopy with several new robotic-assisted and hand-held scopes using the Lazarus 3D Broncho Trainer! - Medtronic is at the forefront of some very cool and innovate technologies utilizing new techniques to ablate heart tissue, making surgery safer. 🎯Now that all these new devices and technologies for cardiothoracic health have launched, the question is, how quickly can they train surgeons to safely adopt these tools to treat patients? #Patientsafety is always the top priority, and Lazarus 3D's platform is at the forefront of the cutting-edge when it comes to dominating the learning curve tied to these highly specialized procedures. 🎯 If you are a #Cardiothoracic Surgeon navigating through the challenges of complex CT/CV procedures, lets connect! Pre-Sure, Lazarus 3D's patient-specific soft-tissue platform for preoperative surgical rehearsals just launched this February after its FDA clearance in Cardiothoracic (late 2023). Some of the first use cases include complex Ewing sarcomas, Pectus Excavatum, valve replacements, and transplants. More to come soon! If you haven't seen the CNN feature on Lazarus 3D which also went live at the #STS2024, check it out here: https://lnkd.in/gsthe5b4 Jacques Zaneveld, Smriti Agrawal Zaneveld, Ph.D., Cheri Waddell 👏

Robotic cardiac surgery is a minimally invasive surgical approach used to treat various heart conditions. It involves the use of specialized robotic systems and surgical instruments operated by a highly trained cardiac surgeon. 1. Minimally Invasive: Robotic surgery typically involves smaller incisions compared to traditional open-heart surgery. 2. Reduced Blood Loss: Smaller incisions and improved visualization often lead to less bleeding during surgery. 3. Shorter Hospital Stay: Patients who undergo robotic cardiac surgery typically have shorter hospital stays compared to open-heart surgery patients. 4. Faster Recovery: The minimally invasive approach and reduced trauma contribute to a quicker recovery, enabling patients to return to their daily activities sooner. 5. Less Scarring: Smaller incisions result in minimal scarring compared to traditional open-heart surgery. 6. Better Surgical Outcomes: Robotic surgery can improve outcomes in certain complex cardiac procedures, such as mitral valve repair, atrial septal defect closure, and coronary artery bypass grafting. 7. Reduced Pain and Discomfort: Patients often experience less postoperative pain and discomfort with robotic surgery. Ortil Healthcare the leading medical tourism company, we're taking you on a journey to discover the forefront of healthcare. Offering state-of-the-art robotic cardiac surgery, we ensures you receive the world-class treatment while enjoying the comforts of medical tourism. So, don't let heart disease define your future. Contact us today for a consultation and discover how Robotic Cardiac Surgery can give you a second chance at life, with minimal scars and maximum results. #RoboticCardiacSurgery #MinimallyInvasiveSurgery #HeartHealth #PrecisionSurgery #ReducedBloodLoss #FasterRecovery #InfectionRisk #LessScarring #SurgicalOutcomes #CardiacHealth #MedicalInnovation #HealthcareAdvancements #OrtilHealthcare #MedicalTourism #HeartDiseaseAwareness #CardiacCare #SurgicalPrecision #HeartProcedure #AdvancedMedicine #MedicalBreakthroughs #HeartRecovery #InnovativeHealthcare #RoboticSurgeryBenefits #PatientWellness #HeartCareJourney

New Surgical Technique for Pulsatile Tinnitus Shows Promising Results A recent study published in Laryngoscope Investigative Otolaryngology by Jeong Gum Lee, MD, et al. introduces a tailored re-roofing technique for treating pulsatile tinnitus caused by sigmoid sinus dehiscence (SSD) or diverticulum. This novel surgical approach aims to improve patient outcomes by reducing surgical time and minimizing complications. Key Findings: Participants: 12 patients diagnosed with SSD, with 7 undergoing surgery. Techniques Compared: Tailored Re-Roofing (TRR) and Transmastoid Resurfacing (MRS). Outcomes: TRR reduced the Korean Tinnitus Handicap Inventory (K-THI) score from 55.0 preoperatively to 4.0 postoperatively. MRS reduced the K-THI score from 41.0 to 15.0. Average surgical time: TRR - 77.5 minutes, MRS - 174.0 minutes. Advantages of TRR: Smaller incisions, reduced risk of complications, and shorter operation times. Implications: The TRR technique offers a less invasive and more efficient alternative to conventional methods, potentially setting a new standard for treating pulsatile tinnitus associated with SSD. Further studies are needed to validate these findings and explore long-term outcomes. For more details, read the full study here:  https://lnkd.in/gWV5b5sc #PulsatileTinnitus #MedicalResearch #SurgicalInnovation #Otolaryngology #HealthcareAdvancements

𝗧𝗵𝗲 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗼𝗳 𝗰𝗮𝗿𝗱𝗶𝗼𝘁𝗵𝗼𝗿𝗮𝗰𝗶𝗰 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 𝗶𝘀 𝘂𝗻𝗱𝗲𝗿𝗴𝗼𝗶𝗻𝗴 𝗮 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝘃𝗲 𝘀𝗵𝗶𝗳𝘁. Advancements in surgical techniques, risk stratification models, and data-driven analytics are ushering in an era of 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 and 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝗰𝗲𝗻𝘁𝗿𝗶𝗰 𝗰𝗮𝗿𝗲. Robotic-assisted surgery and a focus on minimally invasive approaches are further refining the field, paving the way for 𝘁𝗮𝗶𝗹𝗼𝗿𝗲𝗱 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀 and 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀. ➡ https://lnkd.in/gDZMy-DG #cardiothoracicsurgery #roboticassistedsurgery #patientcare #healthcareadvancements #surgicalinnovation #surgicaladvancements #cardiovascularhealth #cardiacsurgery #heartsurgery #europeanhhm #EHHM

This study examines how the learning curve for robotic cardiac surgery operative time evolves when a surgeon with prior experience moves to a new team. A retrospective analysis of 103 cases at Weill Cornell Medicine shows that total operative time decreased significantly after the first 30 cases, indicating a period of adaptation to the new surgical environment. #LearningCurve #OperativeTimeReduction #RoboticCardiacSurgery #SurgeonsTransfer

Hey connections...! I'm happy to share my article about "CORONARY PERFORATION " #snsdesignthinkers #snsinstitutions #snsdesignthinking Coronary perforation is a rare but serious complication during certain medical procedures, such as coronary angiography or angioplasty. It involves unintentional damage to the coronary artery, leading to a communication between the inside of the artery and surrounding structures. There are three types of coronary perforation: Type I: Extravasation into the vessel wall without any hemodynamic compromise. Type II: Perforation extending into the pericardial space, leading to a collection of blood around the heart. Type III: Perforation causing cardiac tamponade, a critical condition where the blood accumulation around the heart compresses it, affecting its ability to pump effectively. Each type requires prompt recognition and appropriate intervention to prevent severe consequences. The treatment of coronary perforation depends on the severity of the perforation and its impact on the patient. Here are general approaches: Type I Perforation: May not require specific treatment. Close monitoring and follow-up to ensure stability. Type II Perforation: Interventional procedures like stent placement or balloon inflation can help seal the perforation. Pericardial drainage may be necessary to address blood accumulation around the heart. Type III Perforation: Immediate measures to relieve cardiac tamponade, such as pericardiocentesis (draining fluid from around the heart). Placement of covered stents or embolization devices to seal the perforation. In severe cases, emergency surgical intervention may be needed, including open-heart surgery to repair the perforation and address any associated complications. Timely recognition and a coordinated approach involving interventional cardiologists and cardiac surgeons are crucial for the successful management of coronary perforation.

This article outlines the anesthetic management protocol for minimally invasive cardiac surgery (MICS) at the Bonn Heart Center. It covers preoperative assessment, tailored anesthesia induction, and intraoperative techniques designed to maintain hemodynamic stability and ensure optimal ventilation. Advanced monitoring methods, including transesophageal echocardiography (TEE), #Anesthesia #CardiacSurgery #MinimallyInvasive #PatientOutcomes

We anticipate for the demand in C-arm procedures to increase. The "IMV 2024 Fixed C-arm Market Outlook Report" reveals that 8.3 million exams were performed using fixed C-arms in 2023, with 51% in radiology, 35% in cardiology, and 15% in surgery. Key Notes: •Interventional radiologists (53%) and cardiac/cardiovascular surgeons (47%) are the top users. •23% of survey respondents expected a shift from open surgeries to C-arm-assisted procedures in the next few years. •Hospitals are focusing on vascular surgery (61%), cardiac surgery (54%), and structural heart disease (31%) programs. Share your thoughts! How do you see C-arm systems evolving in surgical imaging? https://lnkd.in/gAVe29w9 #MedicalImaging #HealthcareInnovation #SurgicalTechnology #Radiology #Cardiology #IMVReport